Remote and hybrid roles in European life sciences in 2026

In our experience, this is one of the most consequential career conversations life sciences professionals are having in 2026 and one that many candidates and hiring managers are still getting wrong. Candidates assume flexibility either still works the way it did in 2022 or has been entirely reversed. Hiring managers assume their company's flexibility positioning is more competitive than it actually is. From what we see across hiring processes, the offers that close in 2026 are calibrated to current local market realities, not to last year's policies. This blog is the practical guide to what that reality actually looks like.

The honest answer has three parts, and most candidates and hiring managers oversimplify by grasping at one of them.

Fully remote roles in pharma and biotech are uncommon for permanent positions, but they exist in specific pockets. Roles that are entirely computational and have no laboratory, manufacturing, or significant in-person stakeholder component are the candidates: senior bioinformatics and computational biology positions at AI-native biotechs, certain pharmacovigilance and regulatory consulting roles, and senior medical writing positions. The common pattern in 2026 is that fully remote permanent roles tend to either come from specific employers that have built their operating model around distributed work, or they sit on the contract and interim end of the market, where the candidate is genuinely independent.

Structured hybrid is now the dominant model for office-based functions in big pharma and mid-size biopharma. The most common pattern is three days in the office per week, though it varies meaningfully by employer. Novartis's Choice with Responsibility programme remains relatively flexible, framing the decision around the activities being performed (data analysis at home, lab work, and on-site brainstorming). Pfizer requires approximately 2.5 days on-site. Roche has tightened its expectations meaningfully since 2024. UCB operates a 60/40 hybrid split, with employees expected on-site around 40% of the time. The variance between policies is large enough that "hybrid" as a single word means very different things at different employers.

Bench, manufacturing, and clinical site-based roles have largely returned to full on-site work in 2026, with limited exceptions for administrative or planning days. The work itself doesn't move; a process scientist needs the bench, a Qualified Person needs the manufacturing site, and a clinical research associate needs the trial centre. Companies that pretended otherwise during the pandemic have largely walked back that framing. Country variation also matters substantially. The Netherlands remains the most flexible major European life sciences market 52% of Dutch workers work from home at least part of the week, the highest rate in the EU. Switzerland sits at around 39%. Belgium at 33.9% have teleworked at least once a week. The UK and Germany have tightened more aggressively, particularly in big pharma.

Six functional categories cover most of where hybrid working actually delivers in 2026 European life sciences. The pattern is consistent across our practice: the functions that suit hybrid are the ones where the work is computational, document-led, or stakeholder-coordination-heavy, with limited dependence on physical lab, manufacturing, or clinical infrastructure.

Regulatory Affairs and Quality Assurance are among the strongest hybrid candidates. Submission writing, dossier preparation, GVP authoring, audit preparation, and regulatory intelligence work all happen on screens with the right systems access. The on-site components, health authority meetings, internal cross-functional sessions, inspection responses, and complex review meetings are typically intermittent rather than daily. We consistently see strong candidates in these functions actively filtering out employers requiring more than three days on-site.

Pharmacovigilance and Drug Safety function well in hybrid arrangements for similar reasons. ICSR case processing, signal detection, PSUR and DSUR authoring, and Risk Management Plan development are all screen-based activities supported by systems such as Oracle Argus, ArisG, and Veeva Vault Safety. Inspection response, QPPV duties, and certain critical incident management require on-site presence at specific times, but the day-to-day work is well-suited to a hybrid arrangement. The strongest QPPVs and senior PV physicians often negotiate explicit hybrid arrangements as part of their contract.

Clinical Operations and Project Management fit well at the central operations level. Clinical project managers, clinical data managers, biostatisticians, medical writers, and trial documentation leads can do most of their work remotely. CRA roles and field-based clinical operations are the exception, since they involve site visits and direct trial monitoring. The hybrid-suited central roles are increasingly contested across European employers as candidates evaluate flexibility alongside compensation.

Computational Biology, Bioinformatics, and AI are the most well-suited hybrid and remote functions in the 2026 life sciences. The work is fundamentally computational; the collaboration is increasingly asynchronous and documented; and the candidates are pulled by AI-native employers (Isomorphic Labs, Recursion, Insilico) and tech-adjacent companies that operate on a distributed-by-default model. Pharma companies that still mandate five-day office presence for these roles are systematically losing senior candidates to competitors that don't.

Market Access, HEOR, and Medical Affairs function well in hybrid arrangements at the central strategy level. Health Economics and Outcomes Research analysts, payer engagement strategists, value dossier authors, and Real-World Evidence managers can do most of their work remotely. Field Medical Science Liaisons remain field-based by definition, but the central medical affairs and market access leadership roles are typically structured around three-day or two-day on-site requirements.

Commercial Operations, Communications, and HR round out the hybrid-suited categories. Brand teams, commercial operations leaders, internal communications, and HR business partners typically operate on structured hybrid models. Field-based commercial roles (sales, account management) are the exception; they are field-based rather than office-based, with home-based working time alternating with customer visits.

Remote interviews remain the dominant format for first and often second-round interviews across European life sciences in 2026, even when the role itself is on-site or hybrid. The pattern is typically a remote first round, sometimes a remote second round, and then an in-person assessment for the final stages. Three principles consistently distinguish the candidates who progress from those who don't.

The first principle is technical preparation that takes regulated-industry depth seriously. A senior regulatory affairs interview is not a generic conversation about "compliance"; it requires specific fluency in EU GVP modules, Annex 11 and 22, QMSR, the EU AI Act timelines, or whatever framework is most relevant to the role. A pharmacovigilance interview will probe knowledge of EudraVigilance integration, the GVP Module IX changes expected in Q2 2026, and the specific systems used by the employer. Computational biology and AI interviews increasingly include technical assessments, take-home tasks, and live coding sessions. We consistently see strong CVs eliminated at the first round because the candidate prepared for a generic interview rather than a specialist one. Look at the company's pipeline, modality focus, and recent regulatory submissions. This is publicly available and should shape the conversation.

The second principle is treating the remote interview as a professional setting rather than a casual one. Camera quality, audio clarity, framing, lighting, and a neutral background matter more than candidates often realise, particularly for senior roles where presence and gravitas form part of the assessment. The cost of a strong USB microphone and decent lighting is trivial compared to the role outcome. Test your setup with a friend before any first-round interview. If you are interviewing for a senior position from home in a noisy environment, take the interview in a quiet location, such as a co-working space or a hotel meeting room. Hiring managers are evaluating both your technical credentials and your professional judgement.

The third principle is asking the questions that test whether the company's flexibility positioning is real. Vague answers are a significant signal. Strong questions to ask: "How is the team currently distributed across locations, and how does that affect my day-to-day work?" "What does the actual on-site requirement look like, including any regional or country variation?" "What activities are expected on-site versus what can be done remotely?" "How do managers support hybrid teams in practice? What tools and rhythms have you found work?" Companies that have genuinely thought through hybrid working will have structured, specific answers. Companies that say "we offer flexibility" without details often operate on five-day mandates in practice. The hiring managers who will respect the question are the ones worth working for. The ones who get defensive are telling you something important about the role you're considering.

Two practical specifics worth flagging. Background checks for regulated-industry roles typically take longer than candidates expect, three to six weeks for thorough employment verification, education verification, and criminal record checks across multiple jurisdictions. Plan your timeline accordingly, particularly if you are negotiating a start date around clinical milestones or visa requirements. And for senior roles, expect the interview process to extend over six to ten weeks rather than the two to three weeks of more transactional industries. The sequence typically includes a recruiter screen, a hiring manager screen, a scientific or technical deep dive, a cross-functional panel, an executive interview, and reference checks. Patience and consistent professionalism throughout the process are what distinguish the candidates who close strong offers.

Are remote roles common in pharmaceutical and biotech companies in 2026?

Fully remote permanent roles are uncommon but exist in specific pockets, such as senior computational biology and bioinformatics, some pharmacovigilance and regulatory consulting, and contract or interim positions where the candidate is genuinely independent. Structured hybrid (typically three days in-office) is the dominant model for office-based functions in big pharma and mid-size biopharma, with significant employer-to-employer variation. Bench, manufacturing, and clinical site-based roles are largely on-site by definition. Country variation is large, the Netherlands remains the most flexible major European life sciences market at 52% home-working, with Switzerland (~39%) and Belgium (33.9%) close behind.

Which life sciences functions are most suited to hybrid working?

Six functional categories suit hybrid working in 2026 European life sciences: regulatory affairs and quality assurance; pharmacovigilance and drug safety; clinical operations and project management at the central operations level; computational biology, bioinformatics, and AI (the most thoroughly hybrid-suited category); market access, HEOR, and medical affairs at the central strategy level; and commercial operations, communications, and HR. The common pattern is that work which is computational, document-led, or stakeholder-coordination-heavy fits hybrid well, while bench, manufacturing, clinical site, and field-based roles remain on-site or field-based by definition.

How should candidates approach remote interviews in regulated industries?

Three principles distinguish strong candidates: technical preparation that takes regulated-industry depth seriously (specific fluency in GVP, Annex 22, EU AI Act, or whichever framework is relevant to the role); treating the remote interview as a professional setting (camera, audio, lighting, neutral background, quiet location); and asking questions that test whether the company's flexibility positioning is real (specific, structured answers from the hiring manager are a positive signal; vague answers about "flexibility" without details are a warning). Two practical points: regulated-industry background checks typically take three to six weeks, and senior interview processes typically run six to ten weeks across multiple stages.

Remote and hybrid working in European life sciences in 2026 is no longer a theoretical conversation about whether flexibility is the future. The future has arrived in a structured, employer-by-employer, country-by-country form that defies any single description. The candidates who navigate it well are those who recognise that "hybrid" means very different things at different companies, that some functions suit it more than others, and that asking the right questions during the interview process is the only way to separate genuine flexibility from policy-page rhetoric. The hiring leaders who navigate it well are those who have understood that flexibility is now a recruitment differentiator and that vague positioning costs them, senior candidates. In a market where life sciences unemployment remains under 2% in major European clusters, that cost is real.

This new world of work holds tremendous promise for candidates seeking fulfilling careers on their own terms, and for employers seeking engaged, dynamic teams poised to discover the next big breakthrough. The journey is ongoing, but one thing is clear: flexibility has transformed from an experiment into a competitive advantage in the life sciences, and there’s no going back. It’s a change that’s empowering people and companies alike, and that’s a formula for success that everyone can celebrate.

Looking for your next remote or hybrid opportunity in life sciences?
Panda International partners with leading biotech, medtech, and pharmaceutical companies across the region. Speak to our team today to explore flexible roles that align with your ambitions.